Insomnia News and Research

Latest Insomnia News and Research

Ledipasvir/sofosbuvir combination approved for hepatitis C treatment does not require antiviral drug

The drug approved to treat patients infected with the hepatitis C virus needs no help from other antivirals, according to a study released online this week in the journal Hepatology.

2 Jul 2015

Light may just be the answer for solving sleep problems among lung cancer patients

When you're having trouble sleeping, light is the last thing you assume you need. But according to a pilot study attempting to solve insomnia among lung cancer patients led by University at Buffalo sleep researcher Grace Dean, light may just be the answer.

26 Jun 2015

American Thoracic Society releases recommendations on achieving good quality sleep

The American Thoracic Society has released a policy statement with recommendations for clinicians and the general public on achieving good quality sleep and getting an adequate quantity of sleep.

15 Jun 2015

Veterans who died from drug overdoses also prescribed benzodiazepines for pain

In a recent study, nearly half of all veterans who died from drug overdoses while prescribed opioids for pain were also receiving benzodiazepines, or benzos, which are common medications for the treatment of anxiety, insomnia and alcohol withdrawal. Veterans prescribed higher doses of benzodiazepines while concurrently receiving opioids were at greater risk of overdose death than those on lower doses of benzodiazepines.

15 Jun 2015

Pre-diagnostic short sleep duration, frequent snoring associated with poor cancer-specific survival

A new study suggests that pre-diagnostic short sleep duration and frequent snoring were associated with significantly poorer cancer-specific survival, particularly among women with breast cancer.

10 Jun 2015

Insomnia affects empathy in health care workers and may lead to adverse clinical outcomes

A new study suggests that insomnia decreases empathy in health care workers and may lead to adverse clinical outcomes and medical errors.

9 Jun 2015

New study reports that poor sleep habits increase pain in knee OA

A new study reports that patients with knee osteoarthritis (OA) who have poor sleep habits display greater central sensitization--an amplification of clinical pain. Findings published in Arthritis Care & Research, a journal of the American College of Rheumatology, further show OA patients who catastrophize--consumed by thoughts of pain--had increased central sensitization that was associated with greater clinical pain.

4 Jun 2015

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.

2 Jun 2015

Key lifestyle changes could help reduce risk of cognitive decline

The evidence is mounting: People can reduce their risk of cognitive decline by making key lifestyle changes. That is the conclusion of a new research summary published online today in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

1 Jun 2015

Simple one-hour therapy session cures 73% of people suffering from acute insomnia

A simple one-hour therapy session has helped to cure 73% of people suffering from acute insomnia, according to a new study from Northumbria University released today.

1 Jun 2015

Abbvie presents venetoclax Phase 1 results in patients with multiple myeloma at ASCO 2015

AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.

1 Jun 2015

Poor sleep significantly decreases cognitive performance in autistic and neurotypical children

One night of poor sleep significantly decreases performance on intelligence tests in children with autism spectrum disorder (ASD) and also in neurotypical children (without ASD). This is the conclusion made by researchers at the Hôpital Rivière-des-Prairies, affiliated with the Institut universitaire en santé mentale de Montréal and Université de Montréal.

29 May 2015

Traffic noise could increase risk of mid-riff bulge

Road traffic noise is linked to a heightened risk of developing a mid-riff bulge, indicates research published online in Occupational & Environmental Medicine.

26 May 2015

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Today, Rhodes Pharmaceuticals L.P. announced that Aptensio XR, a once-daily central nervous system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will be available to patients beginning Summer 2015.

22 May 2015

Shiftworkers more likely to develop metabolic disorders

Shiftwork is an occupational health risk of growing significance because it is becoming more common and because of its potential influence on health outcomes, possibly increasing health differences between workers of higher vs lower socioeconomic status.

18 May 2015

Study finds link between PTSD and accelerated aging

In recent years, public health concerns about post-traumatic stress disorder (PTSD) have risen significantly, driven in part by affected military veterans returning from conflicts in the Middle East and elsewhere. PTSD is associated with number of psychological maladies, among them chronic depression, anger, insomnia, eating disorders and substance abuse.

10 May 2015

Orexigen Therapeutics provides update on business and financial results for Q1 2015

Orexigen Therapeutics, Inc. today announced business and financial results for the first quarter ended March 31, 2015.

8 May 2015

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

ViiV Healthcare today announced the start of a Phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay) and rilpivirine (Edurant) as maintenance therapy for adult patients with HIV.

6 May 2015

NTNU researchers find link between sleep disorders and psychiatric problems in young children

Toddlers who take a long time to fall asleep or wake up many times during the night have put many a desperate mom and dad to the test. Tired parents are often told that night waking is part of toddlerhood, and that it will soon pass on its own, but this is not the case for everyone.

6 May 2015

Night shift workers classified as alert insomniacs have highest level of impairment in work productivity

A new study of night shift workers suggests that overnight occupational and cognitive impairment is more strongly correlated to insomnia than it is to sleepiness.

28 Apr 2015

Insomnia News and Research

Latest Insomnia News and Research

Ledipasvir/sofosbuvir combination approved for hepatitis C treatment does not require antiviral drug

Light may just be the answer for solving sleep problems among lung cancer patients

American Thoracic Society releases recommendations on achieving good quality sleep

Veterans who died from drug overdoses also prescribed benzodiazepines for pain

Pre-diagnostic short sleep duration, frequent snoring associated with poor cancer-specific survival

Insomnia affects empathy in health care workers and may lead to adverse clinical outcomes

New study reports that poor sleep habits increase pain in knee OA

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Key lifestyle changes could help reduce risk of cognitive decline

Simple one-hour therapy session cures 73% of people suffering from acute insomnia

Abbvie presents venetoclax Phase 1 results in patients with multiple myeloma at ASCO 2015

Poor sleep significantly decreases cognitive performance in autistic and neurotypical children

Traffic noise could increase risk of mid-riff bulge

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Shiftworkers more likely to develop metabolic disorders

Study finds link between PTSD and accelerated aging

Orexigen Therapeutics provides update on business and financial results for Q1 2015

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

NTNU researchers find link between sleep disorders and psychiatric problems in young children

Night shift workers classified as alert insomniacs have highest level of impairment in work productivity

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Insomnia News and Research

Latest Insomnia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in